InMed Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Vancouver, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
30 June
InMed Pharmaceuticals Inc. has filed 492 SEC EDGAR filings since 17 Jan 2018

SEC filing history

Showing 1-25 of 492 matching filings.

Per page
25
Current page
1
425 File 001-39685

FORM 425

Filing date
22 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-39685

CURRENT REPORT

Filing date
22 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
22 Jul 2026
Reporting date
22 Jul 2026
Next action
Verify source filing
425 File 001-39685

FORM 425

Filing date
20 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Jul 2026
Reporting date
15 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2026
Reporting date
14 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-39685

CURRENT REPORT

Filing date
10 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
10 Jul 2026
Reporting date
06 Jul 2026
Next action
Verify source filing
4

4 filing

Filing date
02 Jul 2026
Reporting date
30 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-91842

SCHEDULE 13D filing

Filing date
10 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jun 2026
Reporting date
20 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Jun 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91842

SCHEDULE 13G filing

Filing date
05 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91842

SCHEDULE 13G filing

Filing date
27 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 May 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
21 May 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-39685

CURRENT REPORT

Filing date
19 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
19 May 2026
Reporting date
19 May 2026
Next action
Verify source filing
10-Q File 001-39685

QUARTERLY REPORT

Filing date
06 May 2026
Reporting date
31 Mar 2026
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
27 Apr 2026
Reporting date
21 Apr 2026
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
03 Apr 2026
Reporting date
03 Apr 2026
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .